The nuclear receptor co-activator protein NCOA7 is a potential prognostic biomarker of breast cancer, a possible driver protein for breast cancer progression and a potential target for anti-metastatic therapy for advanced breast cancer. This evidence concerns the gene NCOA7 and breast cancer.